Xianshu Yang

Small-molecule inhibitors of FABP4/5 ameliorate dyslipidemia but not insulin resistance in mice with diet-induced obesity

T. Kowalski, P. Orth, H. Lan, 2011, Journal of Lipid Research.

Discovery and Hit-to-Lead Optimization of Non-ATP Competitive MK2 (MAPKAPK2) Inhibitors.

M. McCoy, D. Wyss, Charles E Whitehurst, 2011, ACS medicinal chemistry letters.

Application of affinity selection-mass spectrometry assays to purification and affinity-based screening of the chemokine receptor CXCR4.

M. Ziebell, Charles E Whitehurst, Mingxuan Zhang, 2012, Combinatorial chemistry & high throughput screening.

Definitive Metabolite Identification Coupled with Automated Ligand Identification System (ALIS) Technology: A Novel Approach to Uncover Structure-Activity Relationships and Guide Drug Design in a Factor IXa Inhibitor Program.

Y. Liu, S. Hill, E. Sherer, 2016, Journal of medicinal chemistry.

Affinity selection-mass spectrometry screening techniques for small molecule drug discovery.

M. Ziebell, Charles E Whitehurst, D. A. Annis, 2007, Current opinion in chemical biology.

Functional isolation of the Candida albicans FCR3 gene encoding a bZip transcription factor homologous to Saccharomyces cerevisiae Yap3p

M. Raymond, X. Yang, D. Talibi, 2001, Yeast.

Structural characterization of nonactive site, TrkA-selective kinase inhibitors

D. Henze, H. Su, M. Ziebell, 2016, Proceedings of the National Academy of Sciences.

Mass Spectrometry-Based Screening and Characterization of Protein-Ligand Complexes in Drug Discovery

M. Ziebell, E. Nickbarg, Xianshu Yang, 2011 .